INTRODUCTION
============

Equine neosporosis is caused by an obligatory intracellular apicomplexan protozoan parasite, *Neospora caninum.* *N. caninum* belongs to the family Sarcocystidae and closely resembles *Toxoplasma gondii* \[[@b1-kjp-53-2-163]\]. *Neospora hughesi* is a second species of *Neospora* described in the horse \[[@b2-kjp-53-2-163]\]. The parasite infects a broad range of animals including cattle, sheep, goats, deer, horses, and dogs. Although *N. caninum* is an important cause of abortion in cows, as well as various congenital abnormalities in dogs, little is known regarding its pathogenicity and transmission in horses \[[@b3-kjp-53-2-163]\]. Exposure to *Neospora* spp. in horses is not uncommon, clinical disease associated with natural infections in adult horses, however, have been reported in only few cases. Moreover, it is uncertain whether *N. caninum*, *N. hughesi*, or both are responsible for the disease in positive cases since both species cross-react serologically \[[@b4-kjp-53-2-163]\]. In horses, infection with *Neospora* spp. has been associated with neurological disorders, neonatal diseases, and abortion \[[@b5-kjp-53-2-163]\]. Various laboratory techniques have been used to diagnose *N. caninum*-infected animals. Immunohistochemistry is used to demonstrate *N. caninum* in the placenta or fetal tissues \[[@b6-kjp-53-2-163]\]. Serology tests such as indirect fluorescent antibody test (IFAT), immunoblotting (IB), direct agglutination tests, and a wide variety of ELISAs are used to detect specific antibodies in sera of infected animals. In addition, DNA biotechnology can be used to distinguished *N. hughesi* from *N. caninum* \[[@b7-kjp-53-2-163]\].

According to the Jordan Ministry of Agriculture Yearly Statistical Data (2007), the total population of horses is 2,182 heads. In Jordan, the prevalence and risk factors associated with *N. caninum* infection has been reported in dairy herds \[[@b8-kjp-53-2-163]\]. Information regarding the prevalence of *Neospora* spp. in horses is lacking, therefore, the purpose of the study reported here was to determine the seroprevalence of *Neospora* spp. in horses and to identify potential risk factors for neosporosis in horses in Jordan.

MATERIALS AND METHODS
=====================

Study animals and design
------------------------

Total 227 clinically normal horses were enrolled in the study. The horse farms were selected randomly using the records of the Jordanian Ministry of Agriculture. Horses from each farm were selected randomly using a table of random digits. Horses sampled for the study were from 5 of 6 climatic regions in Jordan; Amman, Irbid, Zarqa, Jordan Valley, and Wadi Mousa ([Fig. 1](#f1-kjp-53-2-163){ref-type="fig"}). The 6th region was not sampled due to the lack of horse population. About 40-50 horses were sampled from each region. The study was performed during spring of 2010. Each farmer was interviewed to gather information about each horse, farm characteristics, and herd management. [Table 1](#t1-kjp-53-2-163){ref-type="table"} shows a list of specific data that was collected on each horse and the farm included in the study.

Blood samples
-------------

Whole blood (5 to 10 ml) was collected from the jugular vein of each horse using vacuum plain tubes (Ayset tube^®^, Adana, Turkey) and transported on ice to the laboratory within 2hr. Blood was centrifuged at 5,000 g for 10 min, and sera were harvested and stored in microtubes at -20˚C until analyzed.

Laboratory analysis
-------------------

For determination of *Neospora* spp. seroprevalence, antibodies in sera were detected by an indirect ELISA kit (The HerdChek Anti-*Neosporai caninum* Antibody Test Kit^®^, IDEXX Laboratories, Westbrook, Maine, USA) according to the manufacturer's instructions. The test has a known sensitivity and specificity of 98.6% and 98.9%, respectively. The resulted prevalence was adjusted to the test sensitivity and specificity using the formula published previously \[[@b9-kjp-53-2-163]\].

Statistical analysis
--------------------

The seroprevalence and risk factor analysis of *Neospora* spp. infection were determined using the chi square tests of association \[[@b10-kjp-53-2-163]\]. Variables with a *P*-value of \<0.05 were considered statistically significant.

RESULTS
=======

[Table 1](#t1-kjp-53-2-163){ref-type="table"} shows the distribution of *Neospora* spp. positive and negative horses (n=227) from Jordan with various risk factors that might be associated with the seropositivity to equine neosporosis. The overall seroprevalence of *Neospora* spp. was 3% (7/227 horses). There was a significant regional difference (*P*=0.018) with the positive cases belonging to Amman and Irbid. The following risk factors were not significantly (*P*\>0.05) associated with seroprevalence of *Neospora* spp.: horse age, gender, breed, usage, body condition score on a scale of 1-9 (a score of 1 represents emaciation whereas a score of 9 is a profound obesity), grazing, presence of other animals mixed with the horses in the same property, and a history of previous diseases such as gastrointestinal (colic and diarrhea), respiratory (fever, coughing, naso-ocular discharge), integumentary (dermatitis), and musculoskeletal diseases (lameness) since 1 year before the commencement of the study. Of 227 horses, 186 (82%) received anthelmintic medication at least once or more a year. Ivermectin and/or piprazine were the most commonly used anthelmintics. Greater than or equal to 1 deworming per year was significantly (*P*=0.0017) associated with a reduction in the seroprevalence of *Neospora* spp. (1.6% vs 9.8%). This finding was supported by an effect of any drench reducing the seroprevalence of *Neospora* spp. (*P*=0.0063). Of 186 horses drenched, only 3 cases (1.6%) of *Neospora* infection were identified. In contrast, the other 4 cases of *Neospora* infection were identified from 41 horses (9.8%) that had not been drenched for worms. Testing the association of specific anthelmintic drugs with the seroprevalence of *Neospora* spp. was not possible due to the low seroprevalence of *Neospora*.

DISCUSSION
==========

Neosporosis in horses has been reported from different parts of the world. To the authors' knowledge, this is the first study in Jordan to determine the prevalence of antibodies to *Neospora* spp. and to evaluate risk factors associated with the occurrence of neosporosis in horses. Unfortunately, we were unable to determine which *Neospora* spp. were infected the seropositive horses since both species cross-react serologically \[[@b4-kjp-53-2-163]\]. The results of this study indicated that horses in Jordan are exposed to *Neospora* spp. with an overall seroprevalence of 3%. This percentage is considerably lower than the seroprevalence of *Neospora* infection that have been reported in horses from the United States \[[@b11-kjp-53-2-163]\] and Czech Republic \[[@b12-kjp-53-2-163]\]. In the Middle East, seroprevalence of *Neospora* spp. was reported from Israel \[[@b13-kjp-53-2-163]\] and Saudi Arabia \[[@b14-kjp-53-2-163]\]. The seroprevalence of *Neospora* spp. infection in horses is considerably different among and within countries. These variations might be due to differences in the serological tests used in each study, limitations of the testing methods, and non-standardized controls, and cut-off values applied \[[@b15-kjp-53-2-163]\]. In addition, the study design, criteria for sample collection, different levels of exposure to the various risk, and protective factors for infection or disease might influence the seroprevalence of *Neospora* spp. which make the comparison between results from different studies difficult \[[@b16-kjp-53-2-163]\].

Determining various risk factors and understanding their role in disease transmission and epidemiology is critical for the development and implementation of proper measures to control equine neosporosis. The seroprevalence of *Neospora* spp. was higher in Amman and Irbid compared to other climatic regions of the country. It was noticed that these 2 regions have the highest density of horse population in Jordan. Significant differences in the seroprevalence of *Neospora* spp. among horse groups from various geographical regions were reported from USA \[[@b15-kjp-53-2-163]\]. However, no significant difference was found in the seropositivity rates from 4 districts in Niğde province of Turkey \[[@b17-kjp-53-2-163]\].

The present study showed a non-significant decrease in the seroprevalence of *Neospora* spp. with increased horse age. This result is contrary to the previous report from Israel \[[@b13-kjp-53-2-163]\] which found a significantly higher seroprevalence to *Neospora* spp. as horses get older than 10 years of age (because of an increased likelihood of exposure through horizontal transmission over time). In a Turkish study, a non-significant increase of seroprevalence to *Neospora* spp. (22.2% and 27.2%) was found between 2 age groups; 1-10 and 11-20 years old, respectively \[[@b17-kjp-53-2-163]\]. The absence of significant effect for the gender on the seroprevalence of *Neospora* spp. in this study is in agreement with findings of Villalobos et al. \[[@b18-kjp-53-2-163]\]. The horse breed was also not significantly associated with the seroprevalence to *Neospora* spp. which agrees with the study of Kligler et al. \[[@b13-kjp-53-2-163]\] in Israel. The presence of other animals mixed-in with horses in the same property was also not significantly associated with seroprevalence to *Neospora* spp. In cattle, it is generally accepted that the presence of farm dogs, the definitive host for *N. caninum*, increases the chance of *N. caninum* infection \[[@b19-kjp-53-2-163]\]. The present study showed that the use of anthelmintic medication at least once a year resulted in a significant reduction in the seroprevalence of *Neospora* spp. However, this might be a phenomenon by chance and a better hygiene since owners can invest in anthelmintics. In cattle, various antimicrobial agents have been tested against *N. caninum* in vitro but there is still no safe and effective chemotherapy that clears infection completely \[[@b20-kjp-53-2-163]\]. However, in vitro and in vivo experimental studies have shown a promising effect for toltrazuril and ponazuril on tachyzoites of *N. caninum* in calves \[[@b21-kjp-53-2-163]\]. Further studies are necessary to determine which species, *N. caninum* or *N. hughesi*, infect the horses. Furthermore, detailed studies to better understand various risk factors that affect the transmission of the parasite among horses are warranted.

![Map of Jordan divided into 6 climate regions according to the model of Koppen (anon., 1984). It also indicates the location of 5 sites sampled in this study. 1. Warm temperature rainy (Irbid), 2. Cool steppe (Amman), 3. Cool desert (Zarqa), 4. Warm desert (Jordan Valley), 5. Cool temperate rainy (Wadi Mousa), and 6. Warm steppe (not sampled).](kjp-53-2-163f1){#f1-kjp-53-2-163}

###### 

Regional distribution of *Neospora* spp. positive and negative horses (n=227) from Jordan and the risk factors analysis associated with the occurrence of equine neosporosis

  Variable                                                                            Description   *Neospora* spp.(%)             
  ----------------------------------------------------------------------------------- ------------- -------------------- --------- -----
  Location (climatic region)^[\*](#tfn1-kjp-53-2-163){ref-type="table-fn"}^                                                        
   Amman                                                                              46            20.3                 3 (6.5)   43
   Irbid                                                                              41            18                   4 (9.8)   37
   Zarqa                                                                              45            19.8                 0 (0)     45
   Jordan Valley                                                                      49            21.6                 0 (0)     49
   Wadi Mousa                                                                         46            20.3                 0 (0)     46
  Age (year)                                                                                                                       
   Juvenile \< 3                                                                      21            9.3                  1 (4.7)   20
   Adult 3-10                                                                         142           62.6                 5 (3.5)   137
   old \> 10                                                                          64            28.1                 1 (1.6)   63
  Gender                                                                                                                           
   Female                                                                             96            42.3                 1 (1)     95
   Male and gelding                                                                   131           57.7                 6 (4.6)   125
  Breed                                                                                                                            
   Mixed local                                                                        171           75.3                 5 (3)     166
   Thoroughbred                                                                       56            24.7                 2 (3.6)   54
  Horse usage                                                                                                                      
   Competitive (racing, polo, showing, and jumping)                                   121           53.3                 2 (1.6)   119
   Non-competitive (breeding, working)                                                106           46.7                 5 (4.7)   101
  Body condition score (scale 1-9)                                                                                                 
   Under condition \< 4                                                               18            8                    1 (5.5)   17
   Normal condition 4-5.5                                                             180           79.3                 6 (3.3)   174
   Over condition \> = 6                                                              29            12.7                 0 (0)     29
  Grazing                                                                                                                          
   Yes                                                                                62            27.3                 2 (3.2)   60
   No                                                                                 165           72.7                 5 (3)     160
  Presence of other animals (ruminants, dogs, and donkeys) mixed-in with horses                                                    
   Yes                                                                                121           53.3                 5 (4.1)   116
   No                                                                                 106           46.7                 2 (1.9)   104
  History of previous body systems diseases                                                                                        
   Yes                                                                                88            38.8                 3 (3.4)   85
   No                                                                                 139           61.2                 4 (2.9)   135
  Use of any anthelmintic medication^[\*](#tfn1-kjp-53-2-163){ref-type="table-fn"}^                                                
   Yes                                                                                186           82                   3 (1.6)   183
   No                                                                                 41            18                   4 (9.8)   37
  Number of dewormings since 1 year before start of study (nil to 9)                                                               
   Nil                                                                                41            18.1                 4 (9.8)   37
   1                                                                                  47            20.7                 1 (2.1)   46
   \>1                                                                                139           61.2                 2 (1.4)   137

*P*-value \<0.05.
